ROYAL BANK OF CANADA - AGEX THERAPEUTICS INC ownership

AGEX THERAPEUTICS INC's ticker is AGE and the CUSIP is 00848H108. A total of 58 filers reported holding AGEX THERAPEUTICS INC in Q3 2019. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
ROYAL BANK OF CANADA ownership history of AGEX THERAPEUTICS INC
ValueSharesWeighting
Q2 2022$0450.0%0.00%
Q1 2022$0450.0%0.00%
Q4 2021$0450.0%0.00%
Q3 2021$045
-67.4%
0.00%
Q2 2021$0
-100.0%
138
-72.8%
0.00%
Q1 2021$1,0000.0%507
-16.3%
0.00%
Q4 2020$1,0006060.0%0.00%
Q3 2020$0
-100.0%
606
-57.6%
0.00%
Q2 2020$1,000
-50.0%
1,429
-35.3%
0.00%
Q1 2020$2,0002,207
+3295.4%
0.00%
Q4 2019$0
-100.0%
65
-91.5%
0.00%
Q3 2019$1,000
-50.0%
765
+35.4%
0.00%
Q2 2019$2,0000.0%565
+34.5%
0.00%
Q1 2019$2,000
+100.0%
420
-8.9%
0.00%
Q4 2018$1,0004610.00%
Other shareholders
AGEX THERAPEUTICS INC shareholders Q3 2019
NameSharesValueWeighting ↓
BROADWOOD CAPITAL INC 2,997,156$2,038,0660.18%
Beirne Wealth Consulting Services, LLC 18,000$16,0770.01%
Strategic Wealth Investment Group, LLC 92,603$62,9700.01%
Prescott General Partners LLC 185,185$125,9260.01%
Summit X, LLC 37,000$25,1600.01%
Sigma Planning Corp 181,385$123,3420.01%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 144,770$98,4440.00%
Piscataqua Savings Bank 1,000$6800.00%
UBS Group AG 235$1600.00%
BNP PARIBAS FINANCIAL MARKETS 74$500.00%
View complete list of AGEX THERAPEUTICS INC shareholders